Hydrochloric Acid

Hydrochloric Acid

SCHEMBL219524

C1=CCC([Hf+2](=C(c2ccccc2)c2ccccc2)c2cccc3c2Cc2ccccc2-3)=C1.[Cl-].[Cl-]

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
PNMT P11086 1/20 0.33
HTR7 P34969 1/20 0.31
HTR2B P41595 1/20 0.31
DRD2 P14416 1/20 0.31
DRD4 P21917 1/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9247921 0.89 NPC1 (0.37) SRD5A2NPC1RAB9APNMTHTR7
Hydrochloric Acid SCHEMBL217757 0.86 NPC1 (0.40) SRD5A2NPC1RAB9APNMTHTR7
Hydrochloric Acid SCHEMBL10320221 0.85 PNMT (0.41) SRD5A2NPC1RAB9APNMTHTR7
Hydrochloric Acid SCHEMBL2141414 0.83 PNMT (0.36) SRD5A2NPC1RAB9APNMTHTR7
Hydrochloric Acid SCHEMBL819870 0.83 NPC1 (0.35) SRD5A2NPC1RAB9APNMTHTR7
Hydrochloric Acid SCHEMBL18420425 0.83
Hydrochloric Acid SCHEMBL5084090 0.83 PNMT (0.34) SRD5A2NPC1RAB9APNMTDRD2
Hydrochloric Acid SCHEMBL2140601 0.81 PNMT (0.34) NPC1RAB9APNMTDRD2DRD4
Hydrochloric Acid SCHEMBL217435 0.79 PNMT (0.37) SRD5A2NPC1RAB9APNMTHTR7
Hydrochloric Acid SCHEMBL7932674 0.77 SETD7 (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662895-B2 comprising polypropylene which is produced in presence of a metallocene transition metal catalyst and an activator; peak melting point temperature below about 110 degrees C., a tensile set of 40% or less, and greater than or equal to about 60% [r]dyads EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-02-16 US claimed
US-20070117941-A1 Syndiotactic propylene elastomers EXXONMOBIL CHEMICAL PATENTS INC. 2007-05-24 US claimed
US-6982236-B2 Process to polymerize olefins UNIVATION TECHNOLOGIES, LLC (US) 2006-01-03 US claimed
US-6897273-B2 Catalyst composition, method of polymerization and polymer therefrom UNIVATION TECHNOLOGIES, LLC (US) 2005-05-24 US claimed
EP-1392743-A2 CATALYST COMPOSITION, METHOD OF POLYMERIZATION AND POLYMER THEREFROM Univation Technologies LLC (US) 2004-03-03 EP claimed
US-20040039138-A1 Catalyst preparation method WENZEL TIMOTHY T (US) 2004-02-26 US claimed
US-6656866-B2 Metallocene and non-metallocene, homogeneous catalysts, particularly for use in the economical gas and slurry phase processes; spray dried olefin polymerization catalysts UNIVATION TECHNOLOGIES, LLC 2003-12-02 US claimed
US-20030207762-A9 CATALYST PREPARATION METHOD UNIVATION TECHNOLOGIES, LLC 2003-11-06 US claimed
EP-1358216-A2 START-UP PROCEDURE FOR MULTIPLE CATALYST POLYMERIZATION SYSTEMS Univation Technologies LLC (US) 2003-11-05 EP claimed
US-6620894-B2 Calibration; using coordination catalyst UNIVATION TECHNOLOGIES, LLC 2003-09-16 US claimed
US-20020132937-A1 Start-up procedure for multiple catalyst polymerization systems UNIVATION TECHNOLOGIES, LLC 2002-09-19 US claimed
US-20020119890-A1 Catalyst preparation method WENZEL TIMOTHY T (US) 2002-08-29 US claimed
US-20020103310-A1 Catalyst composition, method of polymerization and polymer therefrom UNIVATION TECHNOLOGIES, LLC 2002-08-01 US claimed
WO-2002050127-A2 START-UP PROCEDURE FOR MULTIPLE CATALYST POLYMERIZATION SYSTEMS UNIVATION TECHNOLOGIES, LLC (US) 2002-06-27 WO claimed
WO-2002046250-A2 CATALYST COMPOSITION, METHOD OF POLYMERIZATION AND POLYMER THEREFROM UNIVATION TECHNOLOGIES, LLC (US) 2002-06-13 WO claimed
US-RE36103-E Process for the preparation of a syndiotactic polyolefin and catalyst therefor TARGOR GMBH (DE) 1999-02-16 US claimed
EP-0387691-B1 Process for preparing a syndiotactic polyolefin HOECHST AG (DE) 1995-06-28 EP claimed
US-5132381-A Aluminoxane, Hafnium Metallocene HOECHST AKTIENGESELLSCHAFT (DE) 1992-07-21 US claimed
US-20220324895-A1 DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER UNIV NEW YORK (US) 2022-10-13 US disclosed
EP-0648786-A1 Process for producing alpha-olefin polymer Tosoh Corporation (JP) 1995-04-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324895-A1 DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER ALG1, PPOX, MANBA SRD5A2 3720/4885NPC1 4865/4885RAB9A 3534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.